Helen Rowe @RoweLab
@labrowe.bsky.social
Discovery science driven. Hope to contribute to translating discoveries into new medicines.
I am honoured to receive a Programme Foundation Award from Cancer Research UK on epigenetic regulation of immune evasion in non-small cell lung cancer. Thanks to my co-investigators, collaborators, mentors, lab & @qmulepigenetics.bsky.social for supporting this exciting translational project.
February 2, 2024 at 9:27 AM
I am honoured to receive a Programme Foundation Award from Cancer Research UK on epigenetic regulation of immune evasion in non-small cell lung cancer. Thanks to my co-investigators, collaborators, mentors, lab & @qmulepigenetics.bsky.social for supporting this exciting translational project.
Enlightening review from @KathleenHBurns lab: genesdev.cshlp.org/content/37/2...: LINE-1 activity and jumping contributes to genetic instability in cancer and understanding LINE-1 deregulation could lead to new therapeutic opportunities. A must-read.
January 3, 2024 at 6:02 PM
Enlightening review from @KathleenHBurns lab: genesdev.cshlp.org/content/37/2...: LINE-1 activity and jumping contributes to genetic instability in cancer and understanding LINE-1 deregulation could lead to new therapeutic opportunities. A must-read.
Elegant preprint identifying mutually exclusive targeting of HUSH1 vs. HUSH2 chromatin complexes for silencing dangerous LINE-1 elements in the human genome: www.biorxiv.org/content/10.1...
December 30, 2023 at 1:52 PM
Elegant preprint identifying mutually exclusive targeting of HUSH1 vs. HUSH2 chromatin complexes for silencing dangerous LINE-1 elements in the human genome: www.biorxiv.org/content/10.1...